Physician profile
Eugene Kaplan
NPI 1457419210
$3,264.47
in general payments reported to CMS, 2019-2025
7 companies · $165 in 2025
The $165 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,585 · 2024: $515 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,161 · Food and Beverage: $1,103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,161.45 |
| Food and Beverage | $1,103.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,798.64 | 2023-2024 | Altis, Saffron |
| Valencia Technologies Corporation | $1,342.04 | 2023-2025 | Ecoin Device Kit |
| Astellas Pharma US INC | $36.05 | 2024-2025 | Veozah |
| Novo Nordisk INC | $23.27 | 2024 | Ozempic |
| Intuitive Surgical, INC. | $22.79 | 2023 | Da Vinci Surgical System |
| Abbvie INC. | $22.55 | 2025 | |
| Caldera Medical, INC | $19.13 | 2023 | Desara |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Kaplan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.